Drug Information

Drug General Information
Drug ID
D0M6GC
Former ID
DIB007271
Drug Name
TRU-015
Synonyms
CytoxB20G; XXX_CytoxB20G; CD20 antagonist, Trubion; PF-5212374
Indication Lymphoma [ICD9: 202.8, 208.9; ICD10:C81-C86] Phase 2 [522257]
Company
Trubion Pharmaceuticals Inc; Trubion
Target and Pathway
Target(s) B-lymphocyte antigen CD20 Target Info Antagonist [544418]
KEGG Pathway Hematopoietic cell lineage
References
Ref 522257ClinicalTrials.gov (NCT00634933) Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis. U.S. National Institutes of Health.
Ref 544418TRU-015, a small modular immunopharmaceutical (SMIP?? drug candidate directed against CD20, demonstrates clinical improvement in subjects with rheumatoid arthritis. Arthritis Res Ther. 2007; 9(Suppl 3): P32.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.